Net Asset Value • Jul 1, 2019
Net Asset Value
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 9316D
Alliance Pharma PLC
01 July 2019
ALLIANCE PHARMA PLC
("Alliance" or the "Group")
Block Listing Six Monthly Return
| Name of applicant: | ALLIANCE PHARMA PLC | ||||
| Names of schemes: | a) The Alliance Pharma plc Approved Share Option Plan 2005 b) The Alliance Pharma plc Share Option Plan 2006 c) The Alliance Pharma plc Company Share Option Plan 2015 |
||||
| Period of return: | From: | 28 December 2018 | To: | 28 June 2019 | |
| Number of securities originally admitted at date of admission: | 25,000,000 ordinary shares of 1p each 28 June 2017 |
||||
| Balance of unallotted securities under schemes from previous return: | a) 1,091,266 b) 15,345,688 a) 2,049,922 |
||||
| Plus: The amount by which the block schemes have been increased since the date of the last return (if any increase has been applied for): | a) Nil b) Nil c) Nil |
||||
| Less: Number of securities issued/allotted under schemes during period: | a) 107,725 b) Nil c) 823,825 |
||||
| Equals: Balance under schemes not yet issued/allotted at end of period: | a) 983,541 b) 15,345,688 c) 1,226,097 |
||||
| Name of contact: | Chris Chrysanthou, Company Secretary |
| Telephone number of contact: | Tel. +44 (0)1249 705166 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
BLRURORRKRANOUR
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.